Results 231 to 240 of about 209,966 (285)

Potential biomarkers of idiopathic pulmonary fibrosis: metabonomics driven lipid profiling. [PDF]

J Transl Med
Cai W, Zhang H, Li Z, Cai M, Chen P, Guo N, Song X.   +6 more
europepmc   +1 more source

Evaluation of Factors Affecting Mortality in Patients with Idiopathic Pulmonary Fibrosis: A 10-Year Single-Center Experience. [PDF]

Diagnostics (Basel)
Onyilmaz T, Argun Baris S, Ozturk B, Oksuzler Kizilbay G, Selvi Guldiken G, Boyaci H, Basyigit I.   +6 more
europepmc   +1 more source

EPDR1 Links Fibroblast Dysfunction to Disease Severity in Idiopathic Pulmonary Fibrosis. [PDF]

Cells
Lee JU, Park SL, Kim MK, Seo E, Hwang HG, Kim JH, Chang HS, Park CS.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2018
Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis appears to be increasing in incidence. It requires early recognition and intervention with supportive care and pharmacologic agents to forestall its progression. Lung transplantation may be curative, but the disease may recur in transplanted lungs.
Poletti Venerino, Tomassetti S, Ravaglia Claudia   +2 more
semanticscholar   +9 more sources

Idiopathic pulmonary fibrosis: state of the art for 2023

European Respiratory Journal, 2023
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by worsening respiratory symptoms and physiological impairment.
A. Podolanczuk, C. Thomson, M. Rémy-Jardin, L. Richeldi, F. Martinez, M. Kolb, G. Raghu   +6 more
semanticscholar   +1 more source

Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis.

Annual Review of Pathology, 2021
The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of cell types and signaling pathways. Recurrent alveolar epithelial cell (AEC) injury may occur in the context of predisposing factors (e.g., genetic, environmental ...
B. Moss, S. Ryter, I. Rosas
semanticscholar   +1 more source

Idiopathic Pulmonary Fibrosis

Seminars in Respiratory and Critical Care Medicine, 2012
Idiopathic pulmonary fibrosis (IPF) is a specific form of progressive, chronic fibrosing interstitial lung disease occurring primarily in older adults and limited to the lungs. The prognosis is dire, with half of all patients progressing to death from respiratory failure within 3 to 5 years from initial diagnosis. The pathogenesis of IPF is complex and
Jessica M, Adkins, Harold R, Collard
openaire   +4 more sources

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

American Journal of Respiratory and Critical Care Medicine, 2018
Background: This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society ...
G. Raghu, M. Rémy-Jardin, J. Myers, L. Richeldi, C. Ryerson, D. Lederer, J. Behr, V. Cottin, S. Danoff, F. Morell, K. Flaherty, A. Wells, F. Martinez, A. Azuma, T. Bice, Demosthenes Bouros, K. Brown, H. Collard, A. Duggal, L. Galvin, Y. Inoue, R. Jenkins, T. Johkoh, E. Kazerooni, M. Kitaichi, Shandra L. Knight, G. Mansour, A. Nicholson, S. Pipavath, I. Buendía-Roldán, M. Selman, W. Travis, S. Walsh, K. Wilson   +33 more
semanticscholar   +1 more source

Idiopathic pulmonary fibrosis

Expert Review of Respiratory Medicine, 2007
Idiopathic pulmonary fibrosis (IPF; also known as cryptogenic fibrosing alveolitis) is a distinctive type of chronic fibrosing interstitial pneumonia of unknown cause associated with the histological pattern usual interstitial pneumonia (UIP). UIP is a distinct histological pattern observed in IPF but may also be found in other etiologies.
Joseph P, Lynch, Michael C, Fishbein, Rajeev, Saggar, David A, Zisman, John A, Belperio   +4 more
openaire   +3 more sources